Metabolites, Inhibitors and Activators of Fatty Acid Metabolism

Acetyl-CoA Carboxylase Inhibitors

Product #

Description

Add to Cart

P5585 Palmitic acid BioXtra, ≥99%
S6445 S-2E ≥98% (HPLC), powder
T6575 TOFA ≥98% (HPLC)

Fatty Acid Synthase (FAS) Inhibitors

Product #

Description

Add to Cart

A3145 Apigenin ≥97% (TLC), from parsley, powder
C5490 C75 ≥98% (HPLC), powder
C1251 (+)-Catechin hydrate ≥98% (HPLC), powder
C2389 Cerulenin ≥98% (HPLC), from Cephalosporium caerulens
E4143 (−)-Epigallocatechin gallate ≥95%
G5547 GSK837149A ≥98% (HPLC), solid
72779 Irgasan ≥97.0% (HPLC)
K0133 Kaempferol ≥90% (HPLC), powder
L9283 Luteolin ≥98% (TLC), powder
O9265 Osthole
Q4951 Quercetin ≥95% (HPLC), solid
T4512 (±)-Taxifolin hydrate ≥90% (HPLC)

Metabolites of Fatty Acid Metabolism in Oncogenesis

Product #

Description

Add to Cart

A2056 Acetyl coenzyme A sodium salt ≥93% (HPLC), powder
H6042 n-Heptanoyl coenzyme A lithium salt ≥95% (HPLC)
K2010 α-Ketoglutaric acid sodium salt BioUltra
M4263 Malonyl coenzyme A lithium salt ≥90% (HPLC)
N7505 β-Nicotinamide adenine dinucleotide 2′-phosphate reduced tetrasodium salt hydrate ≥97% (HPLC)
O4126 Oxaloacetic acid ≥97% (HPLC)
75447 2-Oxoadipic acid ≥95.0% (HPLC)
C3434 Sodium citrate tribasic dihydrate BioXtra, ≥99.0% (titration)
76455 (R)-Sodium 2,3-dihydroxyisovalerate hydrate ≥95.0% (CE)
F1506 Sodium fumarate dibasic ≥99%
40487 Sodium cis-homoaconitate tribasic ≥97.0% (HPLC)
48488 Sodium (±)-homocitrate tribasic ≥90% (HPCE)
11161 Sodium (R)-β-hydroxyisobutyrate ≥96.0%
36105 (±)-Sodium β-hydroxyisobutyrate ≥96.0%
P9767 Sodium palmitate ≥98.5%
P5280 Sodium pyruvate powder, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99%
S5047 Sodium succinate dibasic hexahydrate BioXtra, ≥99%
59464 Trisodium 2-methylcitrate, racemic mixture of diastereomers ≥85% (mixture of diastereomers, NMR)

Monoacylglycerol Lipase Inhibitors

Product #

Description

Add to Cart

A2984 N-Arachidonylmaleimide ≥98% (HPLC)
J3455 JZL 184 hydrate ≥97% (HPLC)
U3010 URB602 ≥98% (HPLC)

Other Inhibitors of Fatty Acid Metabolism in Oncogenesis

Product #

Description

Add to Cart

M5693 MEDICA 16 powder, ≥97% (HPLC)
O4139 Orlistat ≥98%, solid
P0025 Platensimycin ≥90% (HPLC), from Streptomyces platensis